Brainstorm Cell Therapeutics, Inc. (BCLI)
0.9729
+0.01
(+1.34%)
USD |
OTCM |
Nov 10, 16:00
Brainstorm Cell Therapeutics Total Return Level : 0.9729 for Nov. 10, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 10, 2026 | 0.9729 |
| November 09, 2026 | 0.96 |
| November 06, 2026 | 0.90 |
| November 05, 2026 | 0.86 |
| November 04, 2026 | 0.8261 |
| November 03, 2026 | 0.85 |
| November 02, 2026 | 0.957 |
| October 30, 2026 | 0.8601 |
| October 29, 2026 | 0.9087 |
| October 28, 2026 | 0.7998 |
| October 27, 2026 | 0.7999 |
| October 26, 2026 | 0.7722 |
| October 23, 2026 | 0.8219 |
| October 22, 2026 | 0.776 |
| October 21, 2026 | 0.77 |
| October 20, 2026 | 0.80 |
| October 19, 2026 | 0.77 |
| October 16, 2026 | 0.7791 |
| October 15, 2026 | 0.80 |
| October 14, 2026 | 0.835 |
| October 13, 2026 | 0.8316 |
| October 12, 2026 | 0.8516 |
| October 09, 2026 | 0.9495 |
| October 08, 2026 | 0.9137 |
| October 07, 2026 | 0.9001 |
| Date | Value |
|---|---|
| October 06, 2026 | 1.03 |
| October 05, 2026 | 1.05 |
| October 02, 2026 | 0.9302 |
| October 01, 2026 | 1.00 |
| September 30, 2026 | 0.95 |
| September 29, 2026 | 0.92 |
| September 28, 2026 | 0.936 |
| September 25, 2026 | 0.97 |
| September 24, 2026 | 0.9498 |
| September 23, 2026 | 0.8701 |
| September 22, 2026 | 0.9434 |
| September 21, 2026 | 0.87 |
| September 18, 2026 | 0.90 |
| September 17, 2026 | 0.98 |
| September 16, 2026 | 0.979 |
| September 15, 2026 | 1.04 |
| September 14, 2026 | 1.063 |
| September 11, 2026 | 1.08 |
| September 10, 2026 | 1.03 |
| September 09, 2026 | 1.00 |
| September 08, 2026 | 0.99 |
| September 04, 2026 | 1.05 |
| September 03, 2026 | 1.07 |
| September 02, 2026 | 1.25 |
| September 01, 2026 | 1.168 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| NovelStem International Corp. | 0.0078 |
| Summit Therapeutics, Inc. | 17.83 |
| Kezar Life Sciences, Inc. | 7.29 |
| Protara Therapeutics, Inc. | 2.43 |
| Clene, Inc. | 4.41 |